Hi MondoMy interpretation is much the same with respect to the...

Hi Mondo

My interpretation is much the same with respect to the use of the word "may". Near-term payables would likely be raw materials, fast moving consumables, and SG&A specific costs. Anything non-essential can hopefully be delayed as can be certain payables within reason to the suppliers.

I would expect that bridging loan finance should be possible assuming that the wholly owned assets of the company can be utilised as equity against the loan. I am not too familiar with these loans but assume that this is the high-level nature of these loans. Assuming that the BOD due-diligence is on point (as they have been working this through since Q1 22) one would think it is just a matter of getting to the realisation of the proposed business combination with TRCA.

I am certainly in favour of the loan as opposed to further dilution noting the stock consideration to existing CBR shareholders is circa 200M USD.

Lots to play out here until Q2 23.